NSE · EMAMILTD · FMCG
Emami Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹730 Cr with net profit ₹166 Cr — a 22.81% net margin, versus 34.44% the period before.
Shareholding
As of 2026-06-30
- Promoter54.84%
- Public10.27%
- FII7.87%
- DII27.01%
1,31,617 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.68× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Personal Care - Indian · ranked #5 of 14 by market cap · medians across 12 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Godrej Consumer Products Ltd. | ₹1,09,692 Cr | 242.53 | 8.67 | 14.71% | 12.16% |
| Lenskart Solutions Ltd. | ₹97,951 Cr | 210.99 | 11.21 | 5.65% | 5.6% |
| Dabur India Ltd. | ₹75,588 Cr | 204.86 | 6.62 | 16.59% | 14.36% |
| Cupid Limited | ₹30,793 Cr | 848.15 | 68.31 | 24.01% | 30.26% |
| Emami Limited(this company) | ₹17,619 Cr | 123.06 | 6.03 | 26.51% | 20.51% |
| Jyothy Labs Limited | ₹7,439 Cr | 110.1 | 4.68 | 18.07% | 13.01% |
| Bajaj Consumer Care Ltd. | ₹7,021 Cr | 113.17 | 9.3 | 25.19% | 16.49% |
| Radix Industries (India) Ltd. | ₹212 Cr | 72.38 | 9.09 | 13.72% | 6.41% |
| Thrive Future Habitats Limited | ₹96 Cr | — | 1.82 | -1.94% | -85.25% |
| JHS Svendgaard Laboratories Ltd. | ₹64 Cr | — | 0.37 | -1.1% | -1.89% |
AI analysis
AI-generated · google/gemini-2.5-flashEmami Limited is listed on the Indian markets with a market capitalization of Rs 17685 Cr. The company reported revenue of Rs 3877.3 Cr with a profit margin of 20.51% and an EPS of Rs 17.97. The debt-to-equity ratio stands at 0.04.
Positives
- +Revenue grew 6.5% to Rs 3877.3 Cr in the last financial year.
- +The profit margin for the company is 20.51%.
- +Return on Equity (ROE) is 26.51% and Return on Capital Employed (ROCE) is 27.65%.
- +The debt-to-equity ratio is low at 0.04.
- +Promoter holding of 54.84% demonstrates significant insider ownership.
Negatives
- −The Price-to-Earnings (PE) ratio is 123.52, which is high relative to its EPS of Rs 17.97.
- −Between Mar 2025 and Mar 2026, quarterly revenue decreased from Rs 963.05 Cr to Rs 925.1 Cr.
- −Between Dec 2025 and Mar 2026, quarterly net profit decreased from Rs 319.48 Cr to Rs 143.18 Cr.
- −Promoter pledge percentage is 16.23% of their holding as of June 30, 2026, though it has decreased from 47.68% in March 2019.
- −Earnings per share (EPS) figures are missing for several quarterly periods, including June 2025, Sept 2025, Dec 2025, and Mar 2026.
Financial performance
For the financial year ending March 2025, Emami Limited reported a revenue of Rs 3877.30 Cr. This represents a revenue growth of 6.5%. The net profit for the same period was Rs 806.47 Cr. Quarterly figures show revenue of Rs 925.1 Cr and net profit of Rs 143.18 Cr for Mar 2026.
Profitability & Returns
Emami Limited achieved a profit margin of 20.51% based on its latest annual results. The Return on Equity (ROE) was 26.51%, and the Return on Capital Employed (ROCE) was 27.65%. The Earnings Per Share (EPS) for the last reported period was Rs 17.97.
Balance Sheet
The company maintains a low debt-to-equity ratio of 0.04, indicating a limited reliance on debt financing. The book value per share is Rs 66.99.
Ownership & Pledges
As of June 30, 2026, promoter holding in Emami Limited stood at 54.84%. Institutions held 34.88% of the shares, with FIIs holding 7.87% and DIIs holding 27.01%. The public shareholding was 10.27%. Promoter shares pledged amounted to 16.23% of the total promoter holding.
Regulatory & Surveillance
No information regarding surveillance measures for Emami Limited is available in the provided data.
Data as of — price: 2026-07-30 · financials: Mar 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.